A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study

Condition:   Duchenne Muscular Dystrophy Intervention:   Genetic: delandistrogene moxeparvovec Sponsors:   Sarepta Therapeutics, Inc.;   Hoffmann-La Roche Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials